Chanaxin RSSAuthorisedThis medicine is authorised for use in the European UniontulathromycinMedicineVeterinaryAuthorised
Page contents OverviewProduct detailsAuthorisation detailsAssessment historyNews on ChanaxinApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Chanaxin Active substance tulathromycin International non-proprietary name (INN) or common name tulathromycin Pharmacotherapeutic groupAntibacterials for systemic useMacrolidesAuthorisation details EMA product number EMEA/V/C/005606 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for ChanaxinAdoptedReference Number: EMA/CVMP/570131/2021 English (EN) (183.18 KB - PDF)First published: 21/02/2022ViewNews on ChanaxinMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 202322/05/2023Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 202221/02/2022This page was last updated on 30/01/2024Share this page